V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010764 | 270013055 | 1.67 | 76.9 | Curative (C) | null | 2018-07-14 | Cetuximab + Radiotherapy Load | null | null | 270019087 | GEMCITABINE |
| 270010765 | 270006347 | null | null | Curative (C) | 2018-11-24 | 2018-12-10 | Bevacizumab 7.5mg/kg | N | N | 270019148 | GEMCARBO |
| 270010766 | 270006348 | 1.56 | null | Palliative (P) | 2017-07-20 | 2017-08-09 | BENDAMUSTINE + RITUXIMAB | N | N | 270019170 | RITUXIMAB |
| 270010767 | 270006348 | 1.68 | 116.3 | Palliative (P) | 2018-06-07 | 2018-06-14 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270019170 | CAP + RT |
| 270010768 | 270006348 | null | null | Palliative (P) | 2016-03-31 | 2016-04-11 | Cetuximab 14 day | 02 | N | 270019170 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270010769 | 270017907 | 1.85 | 62.1 | Palliative (P) | 2016-11-13 | 2016-12-01 | CETUXIMAB | N | N | 270019219 | CARBOPLATIN |
| 270010770 | 270018920 | 1.84 | 93.3 | null | 2015-05-01 | 2015-05-05 | CARBOPLATIN + FLUOROURACIL | 2 | N | 270019243 | CARBOPLATIN |
| 270010771 | 270019493 | 1.71 | null | Palliative (P) | 2016-12-01 | 2016-12-13 | SCOT TRIAL | 2 | N | 270019281 | CARBOPLATIN + ETOPOSIDE |
| 270010772 | 270006349 | null | 97.8 | Curative (C) | 2015-03-17 | 2015-03-26 | CAPECITABINE + IRINOTECAN + RT | null | null | 270019333 | CETUXIMAB + RT |
| 270010773 | 270013057 | 1.74 | 82 | null | 2018-09-11 | 2018-10-13 | Fluorouracil + Folinic + RT Bossett | N | N | 270019355 | CARBOPLATIN |
| 270010774 | 270006350 | 0 | 63.8 | Adjuvant (A) | 2017-11-07 | 2017-11-19 | TCF | N | N | 270019409 | CARBOPLATIN + VINORELBINE |
| 270010775 | 270006351 | 1.8 | null | Curative (C) | 2018-11-14 | 2018-11-14 | MITOMYCIN | 2 | N | 270019456 | FLUOROURACIL + MITOMYCIN |
| 270010776 | 270006352 | 1.6 | 83.2 | Curative (C) | 2015-03-14 | 2015-03-31 | CETUXIMAB + RT | N | N | 270019457 | CETUXIMAB + RT |
| 270010777 | 270006353 | null | 88.5 | Adjuvant (A) | 2017-09-13 | 2017-09-24 | TRASTUZUMAB | N | N | 270019538 | CETUXIMAB |
| 270010778 | 270006354 | null | 77 | Not known (9) | 2015-02-07 | 2015-02-07 | Enzalutamide | N | N | 270019701 | GEMCARBO |
| 270010779 | 270013058 | null | null | Palliative (P) | null | 2017-01-16 | CETUXIMAB + IRINOTECAN + MDG | null | null | 270019711 | PEMETREXED |
| 270010780 | 270006355 | 1.67 | null | Curative (C) | 2016-09-29 | 2016-10-06 | Rituximab | N | null | 270019766 | CHOP |
| 270010781 | 270006355 | 1.76 | null | Palliative (P) | 2015-04-26 | 2015-04-29 | Bevacizumab + Cape + Oxali 21day | N | N | 270019766 | CARBOPLATIN + RT |
| 270010782 | 270006355 | null | 95 | Palliative (P) | 2017-05-27 | 2017-06-02 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 270019766 | CETUXIMAB |
| 270010783 | 270006356 | 1.62 | 46 | Neo-adjuvant (N) | 2017-02-16 | 2017-03-02 | GDP | N | Y | 270019922 | CISPLATIN + VINORELBINE + RT |
| 270010784 | 270013060 | 1.58 | 84.2 | Curative (C) | 2016-06-01 | 2018-04-05 | NIVOLUMAB | N | N | 270019952 | CETUXIMAB + RT |
| 270010785 | 270013060 | 1.56 | 51.6 | Curative (C) | 2018-01-16 | 2018-01-19 | CETUXIMAB | N | N | 270019952 | CISPLATIN + VINORELBINE + RT |
| 270010786 | 270006357 | 1.56 | 49.4 | Neo-adjuvant (N) | 2016-11-29 | 2016-12-06 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 270020005 | GEMCARBO |
| 270010787 | 270006357 | 1.57 | null | Adjuvant (A) | 2014-11-22 | 2014-12-02 | CETUXIMAB + RT | N | N | 270020005 | CETUXIMAB + OXALIPLATIN + MDG |
| 270010788 | 270006357 | 1.74 | 94 | Curative (C) | 2016-09-22 | 2016-09-29 | Carboplatin AUC 6 - 10 | N | Y | 270020005 | TCF |
| 270010789 | 270006358 | null | 78.75 | Curative (C) | 2016-12-21 | 2017-01-18 | Carboplatin AUC 6 - 10 | N | N | 270020133 | CARBOPLATIN |
| 270010790 | 270006359 | 1.67 | null | null | 2017-10-20 | 2017-10-23 | FOXTROT TRIAL | N | N | 270020193 | CETUXIMAB + RT |
| 270010791 | 270006360 | 1.68 | 72.7 | null | 2014-09-05 | 2014-09-11 | CETUXIMAB | 2 | N | 270020199 | CETUXIMAB + RT |
| 270010792 | 270006361 | 1.68 | 89 | Curative (C) | 2019-01-21 | 2019-01-26 | FOXTROT TRIAL | 2 | N | 270020249 | CARBOPLATIN + ETOPOSIDE |
| 270010793 | 270006362 | 1.77 | 75.4 | Adjuvant (A) | 2017-10-01 | 2017-10-30 | Fluorouracil96hr infusion+RT(3g/m2) | N | N | 270020264 | FOXTROT TRIAL |
| 270010794 | 270006363 | 1.74 | null | Curative (C) | 2019-02-18 | 2019-02-22 | Raltitrexed | N | N | 270020307 | CETUXIMAB |
| 270010795 | 270006364 | 1.71 | 82.6 | Palliative (P) | null | 2015-02-09 | Cetuximab + FOLFIRI cycle 2 onwards | Y | N | 270020318 | CETUXIMAB |
| 270010796 | 270006365 | 1.6 | 92.2 | Palliative (P) | 2013-11-01 | 2013-12-01 | Cetuximab + Radiotherapy Load | N | N | 270020349 | CAPECITABINE + IRINOTECAN |
| 270010797 | 270013062 | 1.7 | null | Disease modification (D) | 2018-02-19 | 2018-03-08 | Rituximab | N | N | 270020441 | RITUXIMAB |
| 270010798 | 270016142 | null | 83.4 | Palliative (P) | 2015-09-07 | 2015-10-13 | Cisplatin + Etoposide (3 day) | 02 | N | 270020461 | CARBOPLATIN |
| 270010799 | 270017908 | null | 89.4 | Neo-adjuvant (N) | 2017-10-24 | 2017-11-08 | Carboplatin + Etoposide iv&po | N | N | 270020519 | CARBOPLATIN + VINORELBINE |
| 270010800 | 270018921 | 1.76 | 87.5 | Palliative (P) | 2015-08-08 | 2015-08-22 | Cetuximab 7 day (>Cycle 2) | 02 | N | 270020567 | ECF |
| 270010801 | 270006366 | null | 84.3 | Palliative (P) | 2017-02-17 | 2017-02-17 | Enzalutamide | N | N | 270020577 | FLUOROURACIL + MITOMYCIN + RT |
| 270010802 | 270006367 | 1.71 | 65 | Curative (C) | 2017-12-07 | 2017-12-11 | Raltitrexed | N | N | 270020664 | CETUXIMAB + RT |
| 270010803 | 270006367 | 1.55 | 47 | Curative (C) | 2017-05-22 | 2017-06-18 | Carboplatin AUC 2 - 5 | N | N | 270020664 | OXALIPLATIN |
| 270010804 | 270006367 | 1.69 | 77 | Curative (C) | 2017-12-09 | 2017-12-23 | CVP R | 02 | N | 270020664 | CVP R |
| 270010805 | 270006367 | 1.67 | 51.6 | Palliative (P) | 2018-11-13 | 2018-11-13 | Cetuximab + CISPLATIN + FLUOROURACIL | 01 | null | 270020664 | TCF |
| 270010806 | 270006368 | 1.8 | null | Disease modification (D) | 2017-10-06 | 2017-10-11 | Cetuximab + Radiotherapy Load | N | N | 270020919 | CETUXIMAB + CISPLATIN + FU |
| 270010807 | 270006369 | 1.78 | 109 | Palliative (P) | 2014-01-27 | 2014-02-03 | METHOTREXATE | 02 | N | 270020987 | DHAP |
| 270010808 | 270006369 | 1.56 | 32.4 | Curative (C) | 2013-08-04 | 2013-08-04 | Carboplatin AUC 6 - 10 | N | N | 270020987 | CETUXIMAB + RT |
| 270010809 | 270006370 | null | 115 | Curative (C) | 2018-02-15 | 2018-03-09 | GemCarbo Days 1+8 | N | N | 270021077 | CETUXIMAB + CISPLATIN + FU |
| 270010810 | 270006371 | 1.69 | 77.4 | Palliative (P) | 2016-10-11 | 2016-10-11 | RITUXIMAB + prednisolone + VINBLASTINE + prednisolone | N | null | 270021132 | CAPECITABINE + CISPLATIN |
| 270010811 | 270013065 | 1.65 | 52.1 | Adjuvant (A) | 2016-02-27 | 2016-02-29 | Enzalutamide | 02 | N | 270021264 | CARBOPLATIN |
| 270010812 | 270013065 | 1.73 | 74 | Curative (C) | 2016-11-10 | 2016-11-17 | CAPECITABINE + IRINOTECAN | 99 | null | 270021264 | CAPECITABINE + GEMCITABINE |
| 270010813 | 270013065 | 1.52 | 48.7 | Adjuvant (A) | 2015-05-17 | 2015-05-17 | CARBOPLATIN + RT | N | N | 270021264 | CETUXIMAB |